About this trial
The goal of this clinical trial is to asses the effect of non invasive stellate ganglion disrupting on sleep distyrbances on postmenopausal female .
The primary hypothesis:
There is no effect of noninvasive stellate ganglion disrupting on sleep disturbance parameters of postmenopausal women.
There is no effect of noninvasive stellate ganglion disrupting on quality of female's life
Non invasive stellate ganglion disrupting with physical modality TENS will be applied on participants of study group. The participants will be screened for estradiol level and assed for the quality of sleep by specialized questionnaire.
Eligibility criteria
Qualifiers
postmenopausal women who are firstly have sleep disturbances.
Their ages will range from 50- 65 years old.
All patients will be medically stable when attending the study.
BMI≥30.
Disqualifiers
Women with Impaired consciousness.
Inability to communicate with the paramedic because of insufficient language skills.
receiving any medication for sleep disturbances.
Patients who already have sleep disturbances due to another pathological reason or taking any medications which directly affect sleep.
Trial design
Treatments tested in this trial
- Transcutaneous Electrical Nerve Stimulation (TENS)
- Lactium